The NHIC Team
Associate Professor Tina Wong, MBBS, Ph.D
Associate Prof Tina Wong is Head and Senior Consultant in the Glaucoma Service at the Singapore National Eye Centre (SNEC) and Head of the Ocular Therapeutics and Drug Delivery Research Group at the Singapore Eye Research Institute (SERI). She is co-Director of the Ocular Therapeutic Engineering Centre at the Nanyang Technological University (NTU).
Prior to taking up her position in Singapore, she was a Glaucoma Fellow and Research Fellow at Moorfields Eye Hospital in London, UK, where she had completed her general ophthalmic training. She was awarded the Wellcome Trust Vision Research Fellowship for which completed a PhD in Professor Sir Peng Khaw’s laboratory at the Institute of Ophthalmology, University College London. Her research culminated to the award of the Oxford Ophthalmological Congress Fould’s Trophy and the prestigious Moorfields Research Gold Medal.
Her research interests include the application of sustained drug delivery platforms for ophthalmology, ocular inflammation and fibrosis, and the development of new anti-scarring therapeutics. She has received over $8Million of competitive funding and is the recipient of the NMRC Clinician Scientist Award (Investigator and Senior Investigator)
A/Prof Wong has authored extensively in peer-reviewed publications in her research field, contributed to book chapters and authored a book – a patient handbook on glaucoma. She currently holds 9 patents to her name and licensed one of the patents on sustained drug delivery for glaucoma, to a spin-off company, Peregrine Ophthalmic, of which she is co-founder. In 2014, A/Prof Wong together with her collaborators at NTU, were awarded the prestigious President’s Science and Technology Award for this work.
She is involved in both local and international education programmes, courses and regularly presents at international meetings. She is an active member of the Associate Advisory Board of the World Glaucoma Association. Associate Professor Wong is a recipient of the National Clinician Scientist Award in 2010 and 2015 for her work on novel drug delivery platforms for glaucoma, and the Distinguished Service Award at the Asia Pacific Academy of Ophthalmology in Sydney in 2011 for her extensive contributions to ophthalmology and research in glaucoma.
TEO Cher Hwa, MBA
Prior to joining NHIC, Cher Hwa was at A*STAR’s ETPL for seven years, where as Vice President of the Communications & Healthcare Cluster, he oversaw technology transfer activities including IP management, licensing, industry collaboration and translational funding projects in the medtech sector. His technical strengths include medical devices, health IT and medical software.
Before ETPL, Cher Hwa was the Deputy Director (Comms Systems) of ST Electronics where he was responsible for leading the sales & marketing, technical solutioning, and business development for Collaborative and Unified Communication Systems using VoIP Technology. Cher Hwa has more than ten years of industry experience working with Alcatel-Lucent, Radio Frequency Systems and ST Electronics in different capacities where he was responsible for product management, sales & marketing, systems engineering and business development for mission critical systems and communication products.
Cher Hwa holds a Bachelor of Engineering (Hons) in Electronic Engineering from the University of Sheffield and an MBA from the University of Manchester.
Sharron Bennett, Ph.D
Before joining NHIC, Sharron was a Business Analyst in the Innovations team at the Wellcome Trust, London where she was responsible for the due diligence and project management of applications under their Translation Award and Seeding Drug Discovery schemes. Sharron was also involved in the Medical Engineering initiative jointly funded by the Wellcome Trust and EPSRC to establish centres of excellence in the UK.
Prior to this, Sharron spent six years at King’s College London where, as the Senior Technology Transfer Manager, she had responsibility for large stakeholder programmes in addition to the technology transfer activities (such as licensing, spin out company formation) across the biomedical fields and clinical schools at King’s. During this time, Sharron also led a UK Department of Trade & Industry funded initiative aimed at promoting best practice in IP management and commercialization of healthcare innovations from the NHS Trust setting. She also established and led a pan-London research tools initiative (comprising seven London-based academic institutions) designed to commercialise academic research tools.
Sharron holds a Ph.D from the University of Sydney and an Investment Management Certificate from the UK Society of Investment Professionals.
Naga K Modukuru
Business Development Manager
Naga joins NHIC with experience in scientific research and innovation management. As a researcher, Naga spent close to 10 years working on projects related to drug discovery, medicinal chemistry and optimization of biocatalytic processes for active pharmaceutical ingredients. Subsequently, Naga was an Intellectual Property Management & Commercialisation Manager at the Industry Liaison Office, National University of Singapore where he was involved with various aspects of intellectual property, from assessment to commercialisation for Life Sciences and Medical Device related innovations.
Naga holds Masters in Management of Health Industries from ESSEC Business School, Singapore and Masters in Chemistry from the University of Connecticut, USA along with Project Management Professional (PMP®) Certification.
Michael Ho, Ph.D
Prior to joining NHIC, Michael was a Scientist with A*STAR’s IME for five years. As a scientist in the Biomedical Integrated Circuit group, his primary focus was on Medtech innovation, working closely with clinical partners in areas of miniaturised medical device innovation and development. Michael has led and developed close to ten implantable and wearable medical devices, in areas of diagnostic and interventional solutions. He was involved extensively throughout the Medtech development cycle, from identifying the clinical needs through to clinical trials. He was awarded two research grants, and has authored/co-authored more than 30 peer reviewed papers, one book chapter, and filed two patents.
Michael holds a Ph.D from the University of Newcastle, Australia and completed the postgraduate course from Singapore Stanford Biodesign Innovation Class in 2014.
Prior to joining NHIC, Joshua was with the Medical Technology Office of SingHealth where he was responsible for the establishing and promoting initiatives to commercialise technologies that are developed by SingHealth-led teams. Joshua was also involved in the identification and evaluation of unmet clinical needs in various clinical departments based on market and stakeholder analysis. In addition to this, Joshua was also actively contributed in the design and development of medical device prototypes.
Joshua holds a Bachelor of Engineering (Hons) in Biomedical Engineering from the National University of Singapore.
Ng San San
Grants Administrative Executive
Before joining NHIC, San San was assisting in project management in the private sector where she handled the administration and operations of the office and was involved in the finance matters of the project. She was also responsible for monitoring MCST budgets and operations.
Prior to that, she was Assistant Manager at Mount Elizabeth Hospital where she oversaw the operations of the Radiology Department. During this time, she designed and implemented improvements to the service cycle and was team-leader of the department’s 6S Team.
San San holds a Diploma in Accountancy from Association of Chartered Certified Accountants and more than 10 years of experience in office administration and operations with a forte in customer service.
Grants Administrative Executive
Before joining NHIC, Anna was with the Clinical Trials Resource Centre at Singapore General Hospital. She was responsible for Clinical Trials Feasibility Management, Investigator-Initiated Trials grants management, Centre Operation and Audit Management. Anna managed the Centre expansion project and implemented new work processes for the overall efficiency of the Centre.
Prior to this, Anna was a chemist in pharmaceutical companies for seven years where she played an important role in supporting the start-up of the product quality control testing operations. She was responsible for establishing several laboratory management systems and was involved in the qualification of laboratory equipment, the transfer of analytical methodologies and the setting up of drug product stability monitoring programs.
Anna holds a Bachelor of Science in Biotechnology from the Macquarie University and a Specialist Diploma in Clinical Trial Management from Nanyang Polytechnic. She has more than ten years of experience in analytical laboratory/healthcare operations, project management/coordination, procurement and clinical trial administration.